Although there are several studies stating the association of different polymorphisms of ACE and ACE2 with hypertension and other cardiovascular diseases, there is no consistent evidence describing the role of rs2285666 and rs2074192 of ACE2 gene or of I/D and rs4344 polymorphisms of ACE gene in COVID-19 outcomes. This evidence concerns the gene ACE2 and COVID-19.